Stock Pick

9 ASX 200 shares with renewed buy ratings for FY27

Written by

openjargon

in

A group of hands up in the air as if signifying a hearty vote in favour of a motion.

S&P/ASX 200 Index (ASX: XJO) shares rose by 2.77% and delivered total returns, including dividends, of 7% in FY26.

As a new financial year begins, brokers have indicated continuing confidence in several ASX 200 shares.

This week, they renewed their buy calls on the following stocks, with updated 12-month price targets for FY27. 

BHP Group Ltd (ASX: BHP)

Over FY26, the market’s largest ASX 200 mining share skyrocketed 62% to close out the year at $59.40. 

Morgan Stanley renewed its buy rating on BHP shares this week.

The broker has a 12-month price target of $67.50. 

This suggests more than 10% upside over FY27. 

Northern Star Resources Ltd (ASX: NST)

The market’s largest ASX 200 gold mining share rose just 2% to $18.95 over FY26.

UBS reiterated its buy rating on Northern Resources shares this week.

The broker reduced its price target from $24.35 to $23.75. 

This implies potential capital gains of 25% ahead.

ANZ Group Holdings Ltd (ASX: ANZ)

This ASX 200 bank share rose 21% to close out the financial year at $35.35. 

Citi reaffirmed its buy rating on ANZ shares with a price target of $39.25.

This implies potential capital gains of 11% in the new financial year. 

Mineral Resources Ltd (ASX: MIN)

The stock price of this diversified ASX 200 miner rebounded 188% to $62.07 in FY26. 

UBS reaffirmed its buy rating on Mineral Resources shares this week.

The broker lowered its price target from $83 to $79.

This implies potential capital gains of 27% ahead in FY27. 

JB Hi Fi Ltd (ASX: JBH) 

Over FY26, this ASX 200 retail share tumbled 27% to $80.48.

Bell Potter reiterated its buy rating on JB Hi-Fi shares with a price target of $87.

This implies potential capital gains of 8% over FY27.

Neuren Pharmaceuticals Ltd (ASX: NEU)

This ASX 200 healthcare share rose 26% to $17.75 in FY26. 

Bell Potter reiterated its buy rating on Neuren Pharmaceuticals shares this week.

The broker boosted its 12-month share price target from $22 to $23.50. 

This implies potential capital gains of 32% ahead.

Resolute Mining Ltd (ASX: RSG)

Over FY26, this ASX 200 gold stock ripped 56% to 95 cents per share. 

Macquarie renewed its buy rating on Resolute Mining shares with a price target of $1.55.

This implies potential capital gains of 64% for FY27. 

BlueScope Steel Ltd (ASX: BSL)

The BlueScope Steel share price rose 38% over FY26 to close at $31.87. 

RBC Capital renewed its buy rating on the ASX 200 materials share this week. 

The broker raised its 12-month price target from $35.25 to $38.25.

This suggests a potential 20% upside ahead.

South32 Ltd (ASX: S32)

Over FY26, this ASX 200 mining share rose 34% to finish the year at $3.90. 

UBS reaffirmed its buy rating on South32 shares with a reduced price target of $5.

This implies potential capital gains of 28% ahead.

The post 9 ASX 200 shares with renewed buy ratings for FY27 appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the ‘five best ASX stocks’ for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now…

See the 5 Stocks

* Returns as of 16 June 2026

.custom-cta-button p {
margin-bottom: 0 !important;
}

More reading

Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor Bronwyn Allen has positions in BHP Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended BHP Group and Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More posts